CMS proposes Medicare coverage expansion for TAVR

CMS has proposed expanding Medicare coverage for transcatheter aortic valve replacement (TAVR) procedures, which could increase market share for Edwards Lifesciences relative to competitors Medtronic and Boston Scientific. The proposal reflects evolving reimbursement policies for cardiac interventions.